Filament Labs company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

patientio.com

Founded Year

2013

Stage

Acquired | Acquired

Total Raised

$4.34M

About Filament Labs

Filament Labs is building PatientIO, a care plan delivery platform that helps health professionals create fully-customizable care plans that can be seamlessly delivered to patients outside the clinic. Patients receive treatment-specific tasks, reminders and educational content directly on their smartphones, helping health professionals manage patient health behaviors between doctor visits.

Filament Labs Headquarter Location

800 W. Cesar Chavez

Austin, Texas, 78701,

United States

737-703-5669

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Filament Labs

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Filament Labs is included in 1 Expert Collection, including Digital Health.

D

Digital Health

13,070 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Filament Labs Patents

Filament Labs has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/4/2014

Health informatics, Health economics, Medical terminology, Nursing, Electronic health records

Application

Application Date

12/4/2014

Grant Date

Title

Related Topics

Health informatics, Health economics, Medical terminology, Nursing, Electronic health records

Status

Application

Latest Filament Labs News

Athenahealth acquires second company from accelerator program

Aug 29, 2016

Patient IO helps patients track and manage their care. Courtesy/Patient IO website Watertown health IT company athenahealth said Monday that it has acquired a second company from its accelerator program, with the acquisition of Austin-based patient coordination company Filament Labs Inc. Financial terms of the deal were not disclosed. Patient IO helps patients track and manage their care. Courtesy/Patient IO website Filament Labs Inc., a Techstars Austin company that does business as Patient IO, is a mobile and web app that makes patient care an easy-to-follow to-do list, whether helping educate a patient on his or her condition, helping patients manage the medications he or she has to take, or tracking self-reported data. The app will be added to athenahealth’s (Nasdaq: ATHN) population health tool, which helps physicians manage patients on a budgeted basis. All 12 Patient IO employees will join athenahealth. “Care coordination and patient self-management is the next big ground on which healthcare will compete,” said Jon Porter , Senior Vice President of Emerging Services of athenahealth, in a release. “Patient IO accelerates our movement towards an exciting strategic milestone: becoming a trusted resource and partner to the patient.” Athenahealth was familiar with the company, having led a $3.3 million funding round for Patient IO in October through its accelerator program More Disruption Please. Prior to that round, Patient IO raised $1.5 million. The athenahealth investment helped advertise Patient IO to athenahealth clients, but the acquisition will now bring the technology more directly into the athenahealth product portfolio. The acquisition is the second athenahealth has made from its More Disruption Please program, which currently boasts over 100 companies. Athenahealth acquired Arsenal Health, a smart scheduling platform, in April 2016. Patient IO will join athenahealth’s Austin offices, with CEO Jason Bornhorst , and the company’s chief technology and chief product officers serving as executive directors of product strategy. “By taking a patient-centered approach to development and embracing the potential of mobile, together we can reach more healthcare organizations than ever before,” said Jason Bornhorst , co-founder and CEO of Patient IO, who is also a Forbes 30 Under 30 in Healthcare winner. “Our combined offering will deliver actionable insights that help our customer organizations transition to a value-based care environment, improving outcomes and quality at every turn.” In addition to being offered to athenahealth clients, Patient IO will still serve its existing roster of 30 clients, and will continue to sell to non-athenahealth clients under its current name. Athenahealth shares, priced at $122.23, were largely unchanged after news of the acquisition was released Monday morning. Jessica Bartlett covers health care, including hospitals, health IT, health policy and insurance, as well as the beer industry. Related Content

  • When was Filament Labs founded?

    Filament Labs was founded in 2013.

  • Where is Filament Labs's headquarters?

    Filament Labs's headquarters is located at 800 W. Cesar Chavez, Austin.

  • What is Filament Labs's latest funding round?

    Filament Labs's latest funding round is Acquired.

  • How much did Filament Labs raise?

    Filament Labs raised a total of $4.34M.

  • Who are the investors of Filament Labs?

    Investors of Filament Labs include athenahealth, More Disruption Please, Mercury Fund and Techstars.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.